臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 2817115
	???header.visitor??? : 27638157 ???header.onlineuser??? : 1376 ???header.sponsordeclaration???

???search.scope???

???search.advance???

???search.login???

???search.administrator???

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"perez e a"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-03-23T07:19:13Z	Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response	Xu B.; Boyle F.; Smith I.; Jackisch C.; Lang I.; Untch M.; Swaby R.F.; Di Cosimo S.; Holmes E.; Piccart-Gebhart M.; Holmes A.P.; De Azambuja E.;Holmes A.P.;Piccart-Gebhart M.;Holmes E.;Di Cosimo S.;Swaby R.F.;Untch M.;Jackisch C.;Lang I.;Smith I.;Boyle F.;Xu B.;Barrios C.H.;Perez E.A.;Azim H.A.;Kim S.-B.;Kuemmel S.;Chiun-Sheng Huang;Vuylsteke P.;Hsieh R.-K.;Gorbunova V.;Eniu A.;Dreosti L.;Tavartkiladze N.;Gelber R.D.;Eidtmann H.;Baselga J.; De Azambuja E.; Barrios C.H.; Perez E.A.; Azim H.A.; Kim S.-B.; Kuemmel S.; CHIUN-SHENG HUANG; Vuylsteke P.; Hsieh R.-K.; Gorbunova V.; Eniu A.; Dreosti L.; Tavartkiladze N.; Gelber R.D.; Eidtmann H.; Baselga J.
臺大學術典藏	2020-03-23T07:19:13Z	Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response	Xu B.; Boyle F.; Smith I.; Jackisch C.; Lang I.; Untch M.; Swaby R.F.; Di Cosimo S.; Holmes E.; Piccart-Gebhart M.; Holmes A.P.; De Azambuja E.;Holmes A.P.;Piccart-Gebhart M.;Holmes E.;Di Cosimo S.;Swaby R.F.;Untch M.;Jackisch C.;Lang I.;Smith I.;Boyle F.;Xu B.;Barrios C.H.;Perez E.A.;Azim H.A.;Kim S.-B.;Kuemmel S.;Chiun-Sheng Huang;Vuylsteke P.;Hsieh R.-K.;Gorbunova V.;Eniu A.;Dreosti L.;Tavartkiladze N.;Gelber R.D.;Eidtmann H.;Baselga J.; De Azambuja E.; Barrios C.H.; Perez E.A.; Azim H.A.; Kim S.-B.; Kuemmel S.; CHIUN-SHENG HUANG; Vuylsteke P.; Hsieh R.-K.; Gorbunova V.; Eniu A.; Dreosti L.; Tavartkiladze N.; Gelber R.D.; Eidtmann H.; Baselga J.
臺大學術典藏	2016	Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial	Piccart-Gebhart M.; Holmes E.; Baselga J.; De Azambuja E.; Dueck A.C.; Viale G.; Zujewski J.A.; Goldhirsch A.; Armour A.; Pritchard K.I.; McCullough A.E.; Dolci S.; McFadden E.; Holmes A.P.; Tonghua L.; Im Y.-H.; CHIUN-SHENG HUANG; D?eras V.; Hillman D.W.; Wolff A.C.; Jackisch C.; Lang I.; Untch M.; Smith I.; Boyle F.; Xu B.; Gomez H.; Suter T.; Gelber R.D.; Perez E.A.; Eidtmann H.; Dinh P.; Di Cosimo S.; Harbeck N.; Tjulandin S.

Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page